TRIO Pharmaceuticals is a biotechnology company pioneering bispecific antibodies for the treatment of cancer with unprecedented potency and selectivity. TRIO's innovative antibody drugs directly stop tumor growth without affecting normal cells and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways.
Market
Cancer treatment
Location
San Diego,
CA,
USA
Coinvestors
Multiple Myeloma Research Foundation, NuFund Venture Group, Life Science Angels